US FDA Approves Generic Hypertension Drug of Zydus Lifesciences

The US Food and Drug Administration (FDA) has approved Zydus Lifesciences’ hypertension drugs Bisoprolol Fumrate and Hydrochlorothiazide tablets in the United States. The US FDA has given clearance to Zydus Lifesciences to market generic medicines in the United States in multiple strengths. With increasing cases of hypertension, the combination of Bisoprolol Fumrate and hydrochlorothiazide is […]

Continue Reading

AstraZeneca and Sanofi gets European Approval for Drugs Preventing RSV for Infants

The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from several infections caused by […]

Continue Reading

US FDA Approves Gilead Sciences Inc.’s Vemlidy to Treat Chronic Hepatitis B in Pediatric Patients

The US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy (tenofivir alafenamide) 25 mg tablets by Gilead Sciences, Inc., to treat chronic hepatitis B virus (HBV) in pediatric patients older than 12 years with compensated liver disease. Vemlidy is a targeted, novel prodrug of tenofovir, which was previously […]

Continue Reading